WSTWEST PHARMACEUTICAL SERVICE...

NYSE westpharma.com


$ 366.51 $ -0.15 (-0.04 %)    

Thursday, 09-May-2024 15:23:17 EDT
QQQ $ 440.84 $ 0.38 (0.09 %)
DIA $ 393.88 $ 3.77 (0.97 %)
SPY $ 519.67 $ 2.27 (0.44 %)
TLT $ 90.66 $ 0.62 (0.69 %)
GLD $ 216.24 $ 1.54 (0.72 %)
$ 366.66
$ 368.52
$ 0.00 x 0
$ 0.00 x 0
$ 354.75 - $ 368.52
$ 310.09 - $ 415.28
423,637
na
27.24B
$ 0.90
$ 47.90
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-25-2024 03-31-2024 10-Q
2 02-20-2024 12-31-2023 10-K
3 10-26-2023 09-30-2023 10-Q
4 07-27-2023 06-30-2023 10-Q
5 04-27-2023 03-31-2023 10-Q
6 02-21-2023 12-31-2022 10-K
7 10-27-2022 09-30-2022 10-Q
8 07-28-2022 06-30-2022 10-Q
9 04-28-2022 03-31-2022 10-Q
10 02-22-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 07-30-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-23-2021 12-31-2020 10-K
15 10-23-2020 09-30-2020 10-Q
16 07-24-2020 06-30-2020 10-Q
17 04-24-2020 03-31-2020 10-Q
18 02-24-2020 12-31-2019 10-K
19 10-29-2019 09-30-2019 10-Q
20 07-29-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
23 10-30-2018 09-30-2018 10-Q
24 07-31-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 02-26-2018 12-31-2017 10-K
27 10-31-2017 09-30-2017 10-Q
28 08-01-2017 06-30-2017 10-Q
29 05-05-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 10-31-2016 09-30-2016 10-Q
32 08-01-2016 06-30-2016 10-Q
33 05-06-2016 03-31-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 11-02-2015 09-30-2015 10-Q
36 08-03-2015 06-30-2015 10-Q
37 05-06-2015 03-31-2015 10-Q
38 02-25-2015 12-31-2014 10-K
39 11-03-2014 09-30-2014 10-Q
40 08-01-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 west-pharmaceutical-servs-q1-2024-adj-eps-156-beats-126-estimate-sales-695400m-beat-670303m-estimate

West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $1.56 per share which beat the analyst consensus estimate o...

 sp-reclaims-5000-as-disappointing-retail-sales-put-fed-cuts-back-on-track-small-caps-shine-whats-driving-markets-thursday

US stocks surge on strong earnings and speculation of Fed rate cuts. S&P 500 rebounds past 5000, Nasdaq 100 pauses. Small c...

 why-herbalife-shares-are-trading-lower-by-around-36-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings.

 west-pharmaceuticals-2024-outlook-cautious-analysts-remain-optimistic

West Pharmaceutical Services reports Q4 2023 adjusted EPS at $1.83, surpassing consensus. Quarterly sales hit $732 million miss...

 west-pharmaceutical-servs-q4-adjusted-eps-183-beats-178-estimate-sales-73200m-miss-73947m-estimate

West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $1.83 per share which beat the analyst consensus estimate o...

 earnings-scheduled-for-february-15-2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on rev...

 keybanc-maintains-overweight-on-west-pharmaceutical-servs-raises-price-target-to-470

Keybanc analyst Paul Knight maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and raises the price target fro...

 transdigm-west-pharmaceutical-thermo-fisher-scientific-and-a-tech-company-on-cnbcs-final-trades

On CNBC’s "Halftime Report Final Trades," Steve Weiss of Short Hills Capital Partners named TransDigm Group Incorporate...

 west-receives-fda-510k-clearance-for-vial2bag-advanced-13mm-admixture-device

West expands administration systems portfolio with new smaller size needle-free admixture device for immediate use IV drug tran...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION